Currently Funded Projects:


FibrOtic Liver Disease (FOLD) Consortium
This study will establish criteria for primary biliary cholangitis case identification using electronic health records, and assemble a multi-site longitudinal cohort of patients with primary biliary cholangitis from a geographically/demographically diverse population.
Funding Source: Intercept Pharmaceuticals, Inc.
PI: Mei Lu, PhD and Stuart Gordon, MD, Henry Ford Health System; Site PI: Jeffrey VanWormer, PhD


The Greater Plains Collaborative
This work as one of PCORI’s PCORNet Clinical Data Research Networks, involves 12 academic medical centers to: 1) create a research ready dataset of more than 1 million patients; 2) involve patients, providers, and health systems throughout the research process; 3) develop processes for practical, patient-centered clinical trials that are seamless with health care operations; and, 4) develop cohorts of patients in ALS, breast cancer, and weight/obesity that can be characterized and surveyed in support of future research.
Funding Source: University of Kansas Medical Center/PCORI
PI: Russ Waitman; Site PI: Jeffrey VanWormer, PhD


Midwestern Collaborative for Treating Obesity in Rural Primary Care

This is a multi-site, clinic-randomized trial comparing three obesity treatments in adults. Interventions are delivered in primary care settings across several rural clinics in the Midwest.
Funding Source: Patient Centered Outcomes Research Institute
PI: Christie Befort, PhD, University of Kansas Medical Center Research; Site PI: Jeffrey VanWormer, PhD


The Sentinel Initiative: Detection and Analysis of Adverse Events Related to Regulated Products in Automated Healthcare Data
This public health surveillance project uses automated health care data across 19 health care organizations with many millions of covered lives to evaluate post market medical product safety, providing the FDA with the ability to analyze information collected during the course of routine health care, such as data from electronic health record systems, administrative and insurance claims databases and medical registries.
Funding Source:
Harvard/FDA
PI:
Richard Platt, Harvard; Site PI: Robert Greenlee, PhD, MPH


RIC: Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging
The broad goal of the Radiation Induced Cancer (RIC) study is to evaluate patterns of medical imaging in pregnancy and pediatrics, cumulative exposure to radiation, and subsequent risk of childhood cancer. To achieve this goal, we are conducting a retrospective, nested case-control study of patients enrolled in 8 integrated health care systems.
Funding Source: University of California - San Francisco/National Cancer Institute
PI: Rebecca Smith-Bindman, UCSF; Site PI/Co-Investigator: Robert Greenlee, PhD, MPH


The Effectiveness, Safety, and Costs of Guideline-Concordant Lung Nodule Care
The aims of this 2-site observational study in the Cancer Research Network are to evaluate individuals who receive varying intensities of diagnostic evaluation for an incidentally detected lung nodule and compare rates of early stage lung cancer, harms, and costs of care.
Funding Source: University of Washington/National Cancer Institute
PI: Farhood Farjah, University of Washington; Site PI/Co-Investigator: Robert Greenlee, PhD, MPH


Recently Completed Projects:


Abstracting Device Settings for Comparative Effectiveness of Single vs. Dual Chamber ICDs
This study abstracted implantable cardioverter defibrillator device settings to support comparative effectiveness research studies of single vs. dual chamber ICDs within a large cohort of patients with left ventricular systolic dysfunction undergoing ICD implantation for primary prevention of sudden cardiac death at seven large health systems within the Cardiovascular Research Network (CVRN).
Funding Source:
Denver Health
PI: Peterson P, UC Denver; Site PI/Co-Investigator: Robert Greenlee, PhD, MPH 


Discharge Order Completeness and 30‐Day Re-hospitalizations in Rural Wisconsin Nursing Home Patients
Our long term objective was to improve hospital-to-nursing home discharge communication and thereby, improve nursing home patient safety. In pursuance of this goal and building upon our strong preliminary data, we proposed to determine the impact that discharge order omissions have on 30-day re-hospitalization in patients discharged from rural Wisconsin hospitals to nursing homes, and to identify how work processes and provider training levels in these hospitals influence discharge order communication.
Funding Source: University of Wisconsin/Wisconsin Partnership Program
PI: Amy Kind, University of Wisconsin; Site PI/Co-Investigator: Robert Greenlee, PhD, MPH


Mini Sentinel Project: Thromboembolic Events After Immunoglobulin Administration
The Blood Safety Continuous Active Surveillance Network (Blood-SCAN) is a Task Order under the Mini Sentinel pilot that aimed to develop a claims-based active surveillance system for FDA-regulated blood components and blood-derived products. As part of the Blood-SCAN activities, we conducted a one-time, retrospective protocol-based assessment of thromboembolic events (TEE) after immunoglobulin administration and validated the algorithms used to identify the exposure and the outcome. There are 13 different FDA approved products of interest. The majority of Ig use is via the intravenous route (IV), though some products are available for intramuscular (IM) or subcutaneous (SC) administration.
Funding Source: Harvard Pilgrim Health Care, Inc./FDA
PI: Richard Platt, Harvard; Site PI: Robert Greenlee, PhD, MPH